A report on RTS,S
Recombinant protein-based malaria vaccine.
- RTS,S8 related topics with Alpha
Malaria vaccine
3 linksVaccine that is used to prevent malaria.
Vaccine that is used to prevent malaria.
The only approved vaccine, as of 2021, is RTS,S, known by the brand name Mosquirix.
Malaria
3 linksMosquito-borne infectious disease that affects humans and other animals.
Mosquito-borne infectious disease that affects humans and other animals.
As of 2020, there is one vaccine for malaria (known as RTS,S) which is licensed for use.
GSK plc
2 linksBritish multinational pharmaceutical and biotechnology company with global headquarters in London, England.
British multinational pharmaceutical and biotechnology company with global headquarters in London, England.
The company developed the first malaria vaccine, RTS,S, which it said in 2014 it would make available for five percent above cost.
World Health Organization
2 linksSpecialized agency of the United Nations responsible for international public health.
Specialized agency of the United Nations responsible for international public health.
As of 2012, the WHO was to report as to whether RTS,S/AS01, were a viable malaria vaccine.
PATH (global health organization)
1 linksInternational, nonprofit global health organization based in Seattle, with 1,600 employees in more than 70 countries around the world.
International, nonprofit global health organization based in Seattle, with 1,600 employees in more than 70 countries around the world.
The PATH Malaria Vaccine Initiative supports several malaria vaccine candidates at various stages of development around the world, including the most advanced candidate, called RTS,S.
Plasmodium falciparum
1 linksUnicellular protozoan parasite of humans, and the deadliest species of Plasmodium that causes malaria in humans.
Unicellular protozoan parasite of humans, and the deadliest species of Plasmodium that causes malaria in humans.
RTS,S is the only candidate as malaria vaccine to have gone through clinical trials.
Circumsporozoite protein
0 linksCircumsporozoite protein (CSP) is a secreted protein of the sporozoite stage of the malaria parasite (Plasmodium sp.) and is the antigenic target of RTS,S, a pre-erythrocytic malaria vaccine currently undergoing clinical trials.
Virus-like particle
0 linksVirus-like particles (VLPs) are molecules that closely resemble viruses, but are non-infectious because they contain no viral genetic material.
Virus-like particles (VLPs) are molecules that closely resemble viruses, but are non-infectious because they contain no viral genetic material.
The first VLP vaccine that addresses malaria, Mosquirix, (RTS,S) has been approved by EU regulators.